Securitas AB
DUS:S7MB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Securitas AB
DUS:S7MB
|
SE |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
CN |
|
B
|
Biogen Inc
SWB:IDP
|
US |
|
C
|
CME Group Inc
XMUN:MX4A
|
US |
|
D
|
De Grey Mining Ltd
F:DGD
|
AU |
Wall St Price Targets
S7MB Price Targets Summary
Securitas AB
According to Wall Street analysts, the average 1-year price target for S7MB is 15.06 EUR with a low forecast of 11.36 EUR and a high forecast of 19.84 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is S7MB's stock price target?
Price Target
15.06
EUR
According to Wall Street analysts, the average 1-year price target for S7MB is 15.06 EUR with a low forecast of 11.36 EUR and a high forecast of 19.84 EUR.
What is the Revenue forecast for Securitas AB?
Projected CAGR
3%
Over the last 9 years, the compound annual growth rate for Revenue has been 6%. The projected CAGR for the next 4 years is 3%.
What is the Gross Profit forecast for Securitas AB?
Projected CAGR
1%
Over the last 9 years, the compound annual growth rate for Gross Profit has been 9%. The projected CAGR for the next 3 years is 1%.
What is the Operating Income forecast for Securitas AB?
Projected CAGR
5%
Over the last 9 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 3 years is 5%.
What is the Pre-Tax Income forecast for Securitas AB?
Projected CAGR
16%
Over the last 9 years, the compound annual growth rate for Pre-Tax Income has been 8%. The projected CAGR for the next 3 years is 16%.
What is the Net Income forecast for Securitas AB?
Projected CAGR
18%
Over the last 9 years, the compound annual growth rate for Net Income has been 8%. The projected CAGR for the next 3 years is 18%.
